Verastem (VSTM) Liabilities and Shareholders Equity: 2018-2025

Historic Liabilities and Shareholders Equity for Verastem (VSTM) over the last 8 years, with Sep 2025 value amounting to $176.9 million.

  • Verastem's Liabilities and Shareholders Equity rose 39.94% to $176.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $606.4 million, marking a year-over-year increase of 14.02%. This contributed to the annual value of $101.5 million for FY2024, which is N/A change from last year.
  • Per Verastem's latest filing, its Liabilities and Shareholders Equity stood at $176.9 million for Q3 2025, which was down 9.89% from $196.3 million recorded in Q2 2025.
  • In the past 5 years, Verastem's Liabilities and Shareholders Equity registered a high of $196.3 million during Q2 2025, and its lowest value of $95.0 million during Q4 2022.
  • For the 3-year period, Verastem's Liabilities and Shareholders Equity averaged around $145.1 million, with its median value being $129.0 million (2024).
  • In the last 5 years, Verastem's Liabilities and Shareholders Equity plummeted by 48.63% in 2021 and then skyrocketed by 90.98% in 2023.
  • Over the past 5 years, Verastem's Liabilities and Shareholders Equity (Quarterly) stood at $108.7 million in 2021, then declined by 12.53% to $95.0 million in 2022, then skyrocketed by 58.56% to $176.2 million in 2023, then fell by 28.26% to $101.5 million in 2024, then spiked by 39.94% to $176.9 million in 2025.
  • Its Liabilities and Shareholders Equity was $176.9 million in Q3 2025, compared to $196.3 million in Q2 2025 and $131.7 million in Q1 2025.